The Impact of Pathogens on Sepsis Prevalence and Outcome
- PMID: 38276162
- PMCID: PMC10818280
- DOI: 10.3390/pathogens13010089
The Impact of Pathogens on Sepsis Prevalence and Outcome
Abstract
Sepsis, a severe global healthcare challenge, is characterized by significant morbidity and mortality. The 2016 redefinition by the Third International Consensus Definitions Task Force emphasizes its complexity as a "life-threatening organ dysfunction caused by a dysregulated host response to infection". Bacterial pathogens, historically dominant, exhibit geographic variations, influencing healthcare strategies. The intricate dynamics of bacterial immunity involve recognizing pathogen-associated molecular patterns, triggering innate immune responses and inflammatory cascades. Dysregulation leads to immunothrombosis, disseminated intravascular coagulation, and mitochondrial dysfunction, contributing to the septic state. Viral sepsis, historically less prevalent, saw a paradigm shift during the COVID-19 pandemic, underscoring the need to understand the immunological response. Retinoic acid-inducible gene I-like receptors and Toll-like receptors play pivotal roles, and the cytokine storm in COVID-19 differs from bacterial sepsis. Latent viruses like human cytomegalovirus impact sepsis by reactivating during the immunosuppressive phases. Challenges in sepsis management include rapid pathogen identification, antibiotic resistance monitoring, and balancing therapy beyond antibiotics. This review highlights the evolving sepsis landscape, emphasizing the need for pathogen-specific therapeutic developments in a dynamic and heterogeneous clinical setting.
Keywords: COVID-19; bacteria; immunity; sepsis; virus.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.Int Immunopharmacol. 2020 Dec;89(Pt B):107087. doi: 10.1016/j.intimp.2020.107087. Epub 2020 Oct 12. Int Immunopharmacol. 2020. PMID: 33075714 Free PMC article. Review.
-
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.Int J Mol Sci. 2021 Feb 20;22(4):2108. doi: 10.3390/ijms22042108. Int J Mol Sci. 2021. PMID: 33672738 Free PMC article. Review.
-
Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis.Front Immunol. 2024 May 8;15:1386586. doi: 10.3389/fimmu.2024.1386586. eCollection 2024. Front Immunol. 2024. PMID: 38779663 Free PMC article.
-
COVID-19 and Sepsis.Turk J Med Sci. 2021 Dec 17;51(SI-1):3301-3311. doi: 10.3906/sag-2108-239. Turk J Med Sci. 2021. PMID: 34590796 Free PMC article. Review.
-
Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis.Front Immunol. 2021 Dec 9;12:792448. doi: 10.3389/fimmu.2021.792448. eCollection 2021. Front Immunol. 2021. PMID: 34956225 Free PMC article.
Cited by
-
Sepsis-Associated Acute Kidney Injury: What's New Regarding Its Diagnostics and Therapeutics?Diagnostics (Basel). 2024 Dec 17;14(24):2845. doi: 10.3390/diagnostics14242845. Diagnostics (Basel). 2024. PMID: 39767206 Free PMC article. Review.
-
An optimal antibiotic selection framework for Sepsis patients using Artificial Intelligence.NPJ Digit Med. 2024 Nov 29;7(1):343. doi: 10.1038/s41746-024-01350-y. NPJ Digit Med. 2024. PMID: 39613924 Free PMC article.
-
Health-Related Quality of Life Among Patients Who Have Survived an Episode of Sepsis in the United States: A Systematic Review.Infect Dis Ther. 2025 Feb;14(2):385-400. doi: 10.1007/s40121-024-01106-x. Epub 2025 Jan 25. Infect Dis Ther. 2025. PMID: 39862376 Free PMC article. Review.
-
Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.CHEST Crit Care. 2024 Dec;2(4):100095. doi: 10.1016/j.chstcc.2024.100095. Epub 2024 Aug 22. CHEST Crit Care. 2024. PMID: 39610848
-
Maternal Infections, Antibiotics, Steroid Use, and Diabetes Mellitus Increase Risk of Early-Onset Sepsis in Preterm Neonates: A Nationwide Population-Based Study.Pathogens. 2025 Jan 17;14(1):89. doi: 10.3390/pathogens14010089. Pathogens. 2025. PMID: 39861049 Free PMC article.
References
-
- Rahmel T., Schmitz S., Nowak H., Schepanek K., Bergmann L., Halberstadt P., Horter S., Peters J., Adamzik M. Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare. PLoS ONE. 2020;15:e0228952. doi: 10.1371/journal.pone.0228952. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical